Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Diabetes. 2010 May;59(5):1117-25. doi: 10.2337/db09-1899.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / pathology*
  • Gastric Inhibitory Polypeptide / metabolism
  • Gastric Inhibitory Polypeptide / physiology
  • Glucagon-Like Peptide 1 / metabolism
  • Glucagon-Like Peptide 1 / physiology
  • Humans
  • Incretins / metabolism*
  • Insulin-Secreting Cells / metabolism*
  • Insulin-Secreting Cells / pathology*
  • Models, Biological

Substances

  • Incretins
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide 1